Dry‑Processed Surface‑Coated Excipients for High‑Performance Tablets (Dry Processed Surface Coated Engineered Excipients, Tech ID: 16‑022)
Technology Overview: This technology uses solvent‑free, dry processing to apply functional coatings to excipients, improving flowability, compressibility, and blend uniformity without altering chemical composition. The process integrates smoothly with existing tableting lines and supports Quality‑by‑Design principles for robust scale‑up.
Industry Pain Point: Wet coating adds cost, complexity, and drying steps while risking variability.
NJIT Solution: Dry‑coated excipients provide superior performance with simpler, greener manufacturing.
Key Features & Advantages
- Solvent‑free, dry coating process
- Better flow and compaction behavior
- Reduced variability and cycle time
- Drop‑in compatibility with standard equipment
- Improved powder flow and compressibility
- Compatible with existing tablet processes
- Reduced manufacturing complexity
Development Stage: TRL 5–6 – Lab & pilot‑scale validation completed.
Target Markets
- Oral solid dosage manufacturing
- Generics & specialty pharma
- Pharmaceutical solid dosage manufacturing
- Generic drug manufacturers
- CDMOs
Market Opportunity
- Pharmaceutical excipients market (2026): ~$9B
- CAGR: ~6–7%
- Projected market size (2035): ~$15–17B
Commercial & IP Details
Inventors: Rajesh Dave, Liang Chen